Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Bladder01:23

Urinary Bladder

1.3K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
1.3K
Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

373
Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
373

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Influence of Age, BMI, and Parity on 3D MRI-Derived Morphology of Pelvic Floor Muscle and Levator Ani Hiatus in Women With Stress Urinary Incontinence.

Lower urinary tract symptoms·2026
Same author

Pirfenidone and its Derivative: Novel Bronchodilators and Leukocyte Airway Inflammation Inhibitors.

American journal of respiratory cell and molecular biology·2026
Same author

Novel pilot-scale advanced liquefaction-anaerobic digestion (ALAD) process for food waste to biogas conversion.

Bioresource technology·2026
Same author

Development and prospective validation of a multitarget urine RNA assay for noninvasive detection of urothelial carcinoma.

iScience·2025
Same author

Wearable, lightweight single-channel EEG for the detection of urinary urgency and voiding intentions.

International journal of surgery (London, England)·2025
Same author

Stimulus-responsive Pickering emulsion droplet-based microreactors for green biphasic catalysis.

Communications chemistry·2025

Related Experiment Video

Updated: Aug 29, 2025

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

23.2K

Randomized controlled trial of intravesical electrical stimulation for underactive bladder.

Limin Liao1,2, Han Deng1,2, Guoqing Chen1

  • 1Department of Urology, China Rehabilitation Research Centre, Rehabilitation School of Capital Medical University, Beijing, China.

BJU International
|September 9, 2022
PubMed
Summary

This study shows a novel intravesical electrical stimulation (IVES) device significantly improved bladder function in underactive bladder (UAB) patients. The device demonstrated safety, with minimal adverse events, warranting further clinical utility research.

Keywords:
bladder voiding efficiencyclinical trialintravesical electrical stimulationpost-void residual urineunderactive bladder

More Related Videos

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.3K
Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation
03:19

Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation

Published on: August 30, 2024

882

Related Experiment Videos

Last Updated: Aug 29, 2025

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

23.2K
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.3K
Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation
03:19

Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation

Published on: August 30, 2024

882

Area of Science:

  • Urology
  • Medical Devices
  • Clinical Trials

Background:

  • Underactive bladder (UAB) poses a significant challenge in urological care.
  • Current treatment options for UAB have limitations, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To assess the efficacy and safety of a new intravesical electrical stimulation (IVES) device for treating UAB.
  • To compare the novel IVES device against conventional IVES in a randomized controlled trial.

Main Methods:

  • A multicenter, prospective, single-blind, randomized controlled trial was conducted with 76 UAB patients in China.
  • Patients were randomized 1:1 to receive conventional IVES or IVES with an open circuit device for 4 weeks.
  • Primary endpoint: change in post-void residual urine volume (PVR); Secondary endpoints: maximum urinary flow rate (Qmax), bladder voiding efficiency (BVE), clean intermittent catheterization (CIC) frequency, and quality of life scores.

Main Results:

  • The novel IVES device group showed a statistically significant reduction in PVR compared to the control group (P < 0.01).
  • Significant improvements in Qmax (P=0.04) and BVE (P<0.01) were observed in the novel IVES group.
  • No significant differences were found in CIC frequency or quality of life scores between groups. Therapy-related adverse events were infrequent and mild, primarily urinary tract infections.

Conclusions:

  • The novel IVES device is effective and safe for improving bladder function in patients with UAB.
  • Further research is recommended to validate the clinical utility and long-term outcomes of this innovative device.